US 10639375
Progesterone formulations
granted A61KA61K31/565A61K31/566
Quick answer
US patent 10639375 (Progesterone formulations) held by Compass Therapeutics LLC expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/565, A61K31/566, A61K31/57, A61K31/573